The microRNA-23b/-27b cluster suppresses prostate cancer metastasis via Huntingtin-interacting protein 1-related
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The microRNA-23b/-27b cluster suppresses prostate cancer metastasis via Huntingtin-interacting protein 1-related
Authors
Keywords
-
Journal
ONCOGENE
Volume 35, Issue 36, Pages 4752-4761
Publisher
Springer Nature
Online
2016-02-22
DOI
10.1038/onc.2016.6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Role of MicroRNAs in Prostate Cancer Pathogenesis
- (2015) You-Lin Wang et al. Clinical Genitourinary Cancer
- Dietary Supplement 4-Methylumbelliferone: An Effective Chemopreventive and Therapeutic Agent for Prostate Cancer
- (2015) Travis J. Yates et al. JNCI-Journal of the National Cancer Institute
- Dietary Supplement 4-Methylumbelliferone: An Effective Chemopreventive and Therapeutic Agent for Prostate Cancer
- (2015) Travis J. Yates et al. JNCI-Journal of the National Cancer Institute
- Altered Fibroblast Growth Factor Receptor 4 Stability Promotes Prostate Cancer Progression
- (2015) Jianghua Wang et al. NEOPLASIA
- Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer
- (2012) Miki Fuse et al. JOURNAL OF HUMAN GENETICS
- Vav3 Enhances Androgen Receptor Splice Variant Activity and Is Critical for Castration-Resistant Prostate Cancer Growth and Survival
- (2012) Stephanie O. Peacock et al. MOLECULAR ENDOCRINOLOGY
- The mutational landscape of lethal castration-resistant prostate cancer
- (2012) Catherine S. Grasso et al. NATURE
- The microRNA -23b/-27b Cluster Suppresses the Metastatic Phenotype of Castration-Resistant Prostate Cancer Cells
- (2012) Reema A. Ishteiwy et al. PLoS One
- Inhibition of Ras for cancer treatment: the search continues
- (2011) Antonio T Baines et al. Future Medicinal Chemistry
- Lessons from yeast for clathrin-mediated endocytosis
- (2011) Douglas R. Boettner et al. NATURE CELL BIOLOGY
- Experimental strategies for microRNA target identification
- (2011) D. W. Thomson et al. NUCLEIC ACIDS RESEARCH
- Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer
- (2011) E S Martens-Uzunova et al. ONCOGENE
- The Sla2p/HIP1/HIP1R family: similar structure, similar function in endocytosis?
- (2010) Irit Gottfried et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MicroRNAs and Metastasis: Little RNAs Go a Long Way
- (2010) D. M. Dykxhoorn CANCER RESEARCH
- Metastamir: The Field of Metastasis-Regulatory microRNA Is Spreading
- (2009) D. R. Hurst et al. CANCER RESEARCH
- The Role of microRNA-221 and microRNA-222 in Androgen-Independent Prostate Cancer Cell Lines
- (2009) T. Sun et al. CANCER RESEARCH
- Osteoblasts modulate Ca2+ signaling in bone-metastatic prostate and breast cancer cells
- (2009) Julia D’Ambrosio et al. CLINICAL & EXPERIMENTAL METASTASIS
- MicroRNAs and prostate cancer
- (2009) Valeria Coppola et al. ENDOCRINE-RELATED CANCER
- Towards the definition of prostate cancer-related microRNAs: where are we now?
- (2009) Paolo Gandellini et al. TRENDS IN MOLECULAR MEDICINE
- Genomic Profiling of MicroRNA and Messenger RNA Reveals Deregulated MicroRNA Expression in Prostate Cancer
- (2008) S. Ambs et al. CANCER RESEARCH
- microRNAs and prostate cancer
- (2008) Xu-Bao Shi et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation
- (2008) Yvonne Tay et al. NATURE
- Ligand-Independent Activation of Androgen Receptors by Rho GTPase Signaling in Prostate Cancer
- (2007) Leah S. Lyons et al. MOLECULAR ENDOCRINOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More